RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer – the S.U.R.G.U.V.A.N.T. trial

RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer – the S.U.R.G.U.V.A.N.T. trial

Abstract Background Peri-operative inflammation has been extensively highlighted in cancer patients as detrimental. Treatment strategies to improve survival for cancer patients through targeting peri-operative inflammation have yet to be devised. Methods We conducted a multi-centre, randomised contr...

Full description

Bibliographic Details
Main Authors: H. Paul Redmond, Peter M. Neary, Marcel Jinih, Emer O’Connell, Niamh Foley, Rolf W. Pfirrmann, Jiang H. Wang, D. Peter O’Leary
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Cancer
Subjects:
Inflammation
Colon cancer
Peri-operative
Metastasis
Recurrence
Online Access:http://link.springer.com/article/10.1186/s12885-018-4641-x

Internet

http://link.springer.com/article/10.1186/s12885-018-4641-x

Similar Items